Lyka: Lyka Labs jumps after getting CDSCO nod for diabetic drug
Lyka Labs rallied 4.65% to Rs 156.50 after the company received the Central Drug Standard Control Organisation (CDSCO) approval for manufacturing and marketing Pregabalin Gel for the use in patients with Diabetic Neuropathic Pain.
Read full article »
Lyka is an India-based company that manufactures and distributes active pharmaceutical ingredients for the healthcare industry.
Read more